These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11442143)

  • 1. On the association between valproate and polycystic ovary syndrome.
    Genton P; Bauer J; Duncan S; Taylor AE; Balen AH; Eberle A; Pedersen B; Salas-Puig X; Sauer MV
    Epilepsia; 2001 Mar; 42(3):295-304. PubMed ID: 11442143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.
    Stephen LJ; Kwan P; Shapiro D; Dominiczak M; Brodie MJ
    Epilepsia; 2001 Aug; 42(8):1002-6. PubMed ID: 11554885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
    Hu X; Wang J; Dong W; Fang Q; Hu L; Liu C
    Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluate the effects of antiepileptic drugs on reproductive endocrine system in newly diagnosed female epileptic patients receiving either Valproate or Lamotrigine monotherapy: A prospective study.
    Sidhu HS; Srinivasa R; Sadhotra A
    Epilepsy Res; 2018 Jan; 139():20-27. PubMed ID: 29144993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovarian syndrome in women with epilepsy: a review.
    Duncan S
    Epilepsia; 2001; 42 Suppl 3():60-5. PubMed ID: 11520327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate and the polycystic ovarian syndrome: final thoughts.
    Herzog AG; Schachter SC
    Epilepsia; 2001 Mar; 42(3):311-5. PubMed ID: 11442145
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.
    Isojärvi JI; Rättyä J; Myllylä VV; Knip M; Koivunen R; Pakarinen AJ; Tekay A; Tapanainen JS
    Ann Neurol; 1998 Apr; 43(4):446-51. PubMed ID: 9546324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovary syndrome in women using valproate: a review.
    Bilo L; Meo R
    Gynecol Endocrinol; 2008 Oct; 24(10):562-70. PubMed ID: 19012099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-Induced Polycystic Ovary Syndrome in a Girl with Epilepsy: A Case Study.
    Kawakami Y; Fujii S; Ishikawa G; Sekiguchi A; Nakai A; Takase M
    J Nippon Med Sch; 2018; 85(5):287-290. PubMed ID: 30464147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate.
    Luef G; Abraham I; Trinka E; Alge A; Windisch J; Daxenbichler G; Unterberger I; Seppi K; Lechleitner M; Krämer G; Bauer G
    Epilepsy Res; 2002 Jan; 48(1-2):91-102. PubMed ID: 11823113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the association between valproate and polycystic ovary syndrome: a response and an alternative view.
    Isojärvi JI; Taubøll E; Tapanainen JS; Pakarinen AJ; Laatikainen TJ; Knip M; Myllylä VV
    Epilepsia; 2001 Mar; 42(3):305-10. PubMed ID: 11442144
    [No Abstract]   [Full Text] [Related]  

  • 13. Valproate, hyperandrogenism, and polycystic ovaries: a report of 3 cases.
    Isojarvi JI; Tapanainen JS
    Arch Neurol; 2000 Jul; 57(7):1064-8. PubMed ID: 10891991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and endocrine disorders in women taking valproate for epilepsy.
    Isojärvi JI; Laatikainen TJ; Knip M; Pakarinen AJ; Juntunen KT; Myllylä VV
    Ann Neurol; 1996 May; 39(5):579-84. PubMed ID: 8619542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome and epilepsy--a gynaecological perspective.
    Polson DW
    Seizure; 2003 Sep; 12(6):397-402. PubMed ID: 12915086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: a cross-sectional study.
    Sahota P; Prabhakar S; Kharbanda PS; Bhansali A; Jain V; Das CP; Modi M
    Epilepsia; 2008 Dec; 49(12):2069-77. PubMed ID: 18503558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term reproductive endocrine health in young women with epilepsy during puberty.
    Mikkonen K; Vainionpää LK; Pakarinen AJ; Knip M; Järvelä IY; Tapanainen JS; Isojärvi JI
    Neurology; 2004 Feb; 62(3):445-50. PubMed ID: 14872028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study.
    Prabhakar S; Sahota P; Kharbanda PS; Siali R; Jain V; Lal V; Khurana D
    Epilepsia; 2007 Jul; 48(7):1371-7. PubMed ID: 17441994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of women with epilepsy who developed polycystic ovary syndrome owing to the therapy with valproate sodium].
    Minagawa K; Watanabe T; Oyanagi R
    No To Hattatsu; 2013 Jul; 45(4):304-8. PubMed ID: 23951943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Remission of polycystic ovary syndrome associated with valproic acid in an epileptic female].
    Ribacoba-Montero R; Martínez-Faedo C; Díaz-Díaz C; Salas-Puig J
    Rev Neurol; 2003 Apr 1-15; 36(7):639-42. PubMed ID: 12666045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.